Silica Nanoparticles for Delivery of Therapeutics and Imaging Agents
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (10 November 2021) | Viewed by 13808
Special Issue Editor
2. Department of Engineering Science, Oxford University, Parks Road, Oxford OX1 3PJ, UK
Interests: nanoparticles; cancer therapy; cancer imaging; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Silica nanoparticles have been widely used in biomedical applications due to the easy synthesis of different sizes and morphology, their biocompatibility, and easy surface functionalization. Such nanoparticles have shown tremendous potential as adsorbents and carriers of drugs and other therapeutic molecules. Their nanosize allows the particles to easily permeate tumour tissues via passive mechanisms, but the efficacy can be improved by active targeting. The pore sizes and morphology can be tailored to the application, and a wide array of molecules carried to the site of interest.
This Special Issue has the aim of highlighting current progress in the use of silica nanoparticles for the delivery of therapeutic molecules, and imaging agents. Suggested topics include: new synthesis methods for unique morphologies, new approaches in targeted delivery, nanoparticle design for improved uptake in target cells, and modifications of the silica with doping agents or dyes.
Dr. Helen Townley
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- silica nanoparticles
- drug delivery
- cargo
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.